PGL5001 Proof of Concept Study in Inflammatory Endometriosis

NCT01630252 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: PGL5001
DRUG: Placebo
DRUG: PGL5001
DRUG: Placebo
DRUG: PGL5001

Sponsor

PregLem SA